期刊文献+

促红细胞生成素及其衍生物对糖尿病视网膜病变神经保护作用的研究进展 被引量:1

原文传递
导出
摘要 糖尿病视网膜病变(Diabetic Retinopathy,DR)是一种以微循环障碍为特征的疾病,非增生期的病理改变为视网膜毛细血管周细胞选择性丢失、内皮细胞及基底膜增厚、血.视网膜屏障(blood—brainbarrier,BBB)破坏、毛细血管闭塞、微血管瘤形成,而晚期由于大量微血管异常及无灌注区的存在导致视网膜新生血管的形成,严重影响患者的视力。
作者 熊淑毓 许迅
出处 《中华糖尿病杂志》 CAS 2012年第10期635-638,共4页 CHINESE JOURNAL OF DIABETES MELLITUS
  • 相关文献

参考文献33

  • 1Gardner TW,Antonetti DA,Barber AJ. New insights into the pathophysiology of diabetic retinopathy:potential cell-specific therapeutie targets[J].Diabetes Technology and Therapeutics,2000.601-608.
  • 2van Dijk HW,Verbraak FD,Kok PH. Early neurodegeneration in the relina of type 2 diabetic patients[J].Investigative Ophthalmology & Visual Science,2012.2715-2719.
  • 3Kern TS,Barber AJ. Retinal ganglion cells in diabetes[J].The Journal of Physiology,2008.4401-4408.
  • 4Corwin HL,Gettinger A,Fabian TC. Efficacy and safety of epoetin alfa in critically ill patients[J].New England Journal of Medicine,2007.965-976.
  • 5Brines M,Patel NSA,Villa P. Nonerythropoietic,tissueprotective peptides derived from the tertiary structure of erythropoietin[J].Proceedings of the National Academy of Sciences(USA),2008.10925-10930.
  • 6Fisher JW. Erythropoietin:Physiology and pharmacology update[J].Experimental Biology and Medicine,2003.1-14.
  • 7Katavetin P,Tungsanga K,Eiam-Ong S. Antioxidative effects of erythropoietin[J].Kidney International Supplement,2007.S10-S15.
  • 8Jelkmann W,Bohlius J,Hallek M. The erythropoietin receptor in normal and cancer tissues[J].Critical Reviews in Oncology/Hematology,2008.39-61.
  • 9Brines M,Gasso G,Fiordaliso F. Erythropoietin mediales tissue protection through an erythropoietin and common betasubunit heteroreceptor[J].Proceedings of the National Academy of Sciences(USA),2004.14907-14912.
  • 10Kilic E,Kilic U,Soliz J. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways[J].Federation of America Societies for Experimental Biology Journal,2005.2026-2028.

同被引文献17

  • 1Woo M, Hawkins M. Beyond erythropoiesis: emerging metabolic roles of erythropoietin [J]. Diabetes,2014,63(7): 2229-2231.
  • 2Choi D, Schroer SA, Lu SY, et al. Erythropoietin protects against diabetes through direct effects on pancreatic beta cells [J]. J Exp Med,2010,207(13):2831-2842.
  • 3Meng R, Zhu D, Bi Y, et al. Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice [J]. PLoS One, 2013,8(1):e53557.
  • 4Pan Y, Shu JL, Gu HF, et al. Erythropoietin improves insulin resistance via the regulation of its receptor-mediated signaling pathways in 3T3L1 adipocytes [J]. Mol Cell Endocrinol,2013,367(1-2): 116-123.
  • 5Wang L, Teng R, Di L, et al. PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders[J]. Diabetes, 2013, 62(12):4122-4131.
  • 6Wang RH, Kim HS, Xiao C, et al. Hepatic Sirtl deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance [J]. J Clin Invest,2011,121(11):4477-4490.
  • 7Sun C, Zhang F, Ge X, et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP 1B [J]. Cell Metab,2007,6(4):307-319.
  • 8Milne JC, Lambert PD, Schenk S, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes [J]. Nature,2007,450(7170):712-716.
  • 9Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action [J]. Nat Rev Mol Cell Biol,2006,7(2):85-96.
  • 10Teng R, Gavrilova O, Suzuki N, et al. Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production [J]. Nat Commun,2011,2:520.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部